Shuttle Pharmaceuticals Holdings, Inc. — Form 10-Q
Filed September 24, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 18/100
What the filing says
This is a routine quarterly SEC filing (Form 10-Q for period ending 2026-06-30, filed 2026-09-24) by Shuttle Pharmaceuticals Holdings, Inc., a pharmaceutical company with a public market value of ~$4.7M. The filing document listing provided contains only structural metadata and XBRL formatting files; no substantive financial data, revenue, cash position, pipeline updates, partnerships, licensing deals, clinical trial results, or operational metrics are present in the text supplied. Without access to the actual 10-Q content (beyond the filing header), specific counterparties, dollar amounts, and business developments cannot be identified.
Why this rating
Routine quarterly disclosure filing. No concrete business developments, financial results, or material events disclosed in available text. Cannot assess without actual 10-Q content.
See more from September 24, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.